Policy | June 02, 2022
PMBI first time ever crossed Rs. 100 crore sales in May, 2022
Govt. has set a target to increase the number of JanAushadhi Kendras to 10,000 by March 2024
Govt. has set a target to increase the number of JanAushadhi Kendras to 10,000 by March 2024
Focussed campaigns for old age homes, schools/colleges, prisons, brick kilns to be taken up by States/UTs
By 2025, Cipla plans to achieve carbon and water neutrality, zero-waste to landfill, anti-microbial resistance stewardship and green chemistry.
Low-dose atropine has emerged as an effective approach to slow the progression of myopia in children
This expansion announcement came right after raising series B funding of $27 Mn in a round led by Fundamentum Partnership, earlier this month.
Glenmark Pharmaceuticals announced its financial results for the fourth quarter ended March 31, 2022
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD), Motrin Oral Suspension, 100 mg/5 mL, of McNeil Consumer Healthcare (McNeil)
JB, in its new avatar, emerges as the fastest growing pharmaceuticals company in India
The inspection was a Pre-Approval cum cGMP inspection and it covered 15 ANDAs
The integration and transition of the brands are expected to be completed by June 2022.
Subscribe To Our Newsletter & Stay Updated
